Interestingly, protein arginine methyltransferase 1 (PRMT1) is identified as a negative regulator of MHC‐I expression, attenuating CD8+ T cell‐mediated anti‐tumour responses by suppressing IFN‐γ‐induced STAT1 activation. Here, PRMT1 is linked to neoplasm.